Matthias Zehner, Mira Alt, Artem Ashurov, Jory A Goldsmith, Rebecca Spies, Nina Weiler, Justin Lerma, Lutz Gieselmann, Dagmar Stöhr, Henning Gruell, Eric P Schultz, Christoph Kreer, Linda Schlachter, Hanna Janicki, Kerstin Laib Sampaio, Cora Stegmann, Michelle D Nemetchek, Sabrina Dähling, Leon Ullrich, Ulf Dittmer, Oliver Witzke, Manuel Koch, Brent J Ryckman, Ramin Lotfi, Jason S McLellan, Adalbert Krawczyk, Christian Sinzger, Florian Klein
Human cytomegalovirus (HCMV) can cause severe diseases in fetuses, newborns, and immunocompromised individuals. Currently, no vaccines are approved, and treatment options are limited. Here, we analyzed the human B cell response of four HCMV top neutralizers from a cohort of 9,000 individuals. By single-cell analyses of memory B cells targeting the pentameric and trimeric HCMV surface complexes, we identified vulnerable sites on the shared gH/gL subunits as well as complex-specific subunits UL128/130/131A and gO...
November 14, 2023: Immunity